Chronic News and Research

RSS
ASH and ISH release guidelines for diagnosis and treatment of hypertension

ASH and ISH release guidelines for diagnosis and treatment of hypertension

UCLA researchers find no evidence of association between iron levels and atherosclerosis risk

UCLA researchers find no evidence of association between iron levels and atherosclerosis risk

Viewpoints: All eyes on insurers; an employer's perspective on health law; budget peace may not last long

Viewpoints: All eyes on insurers; an employer's perspective on health law; budget peace may not last long

AGA guidelines recommend anti-TNF-α biologic agents to induce remission in Crohn's disease patients

AGA guidelines recommend anti-TNF-α biologic agents to induce remission in Crohn's disease patients

Decreasing levels of reactive oxygen species can break cycle of unhealing wounds

Decreasing levels of reactive oxygen species can break cycle of unhealing wounds

Nonsurgical treatment of periodontal disease does not improve glycemic control in patients with diabetes

Nonsurgical treatment of periodontal disease does not improve glycemic control in patients with diabetes

Professor wins $1M to create medical devices that lead to greater control of prosthetics in soldiers

Professor wins $1M to create medical devices that lead to greater control of prosthetics in soldiers

Illinois healthcare coalition receives $7M grant to establish research network to battle chronic illnesses

Illinois healthcare coalition receives $7M grant to establish research network to battle chronic illnesses

ASH, ISH create new guidelines for diagnosis and treatment of hypertension

ASH, ISH create new guidelines for diagnosis and treatment of hypertension

Cardiovascular disease in asthma needs attention

Cardiovascular disease in asthma needs attention

Researchers discover direct evidence of genetic overlap between cognitive ability and schizophrenia

Researchers discover direct evidence of genetic overlap between cognitive ability and schizophrenia

Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leukemia

Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leukemia

Atara Biotherapeutics secures $38.5M in initial closings under Series B financing

Atara Biotherapeutics secures $38.5M in initial closings under Series B financing

Toddlers’ bedtime resistance may contribute to sleep problems

Toddlers’ bedtime resistance may contribute to sleep problems

New report shows death rates for lung cancer dropping at a faster pace

New report shows death rates for lung cancer dropping at a faster pace

Minorities who are at highest risk of diabetes may benefit from beverage sugar tax

Minorities who are at highest risk of diabetes may benefit from beverage sugar tax

Utah researchers discover naturally occurring genetic variation that cause inflammatory arthritis

Utah researchers discover naturally occurring genetic variation that cause inflammatory arthritis

Secondary conditions can become deadly and affect how long HIV patients stay in hospital

Secondary conditions can become deadly and affect how long HIV patients stay in hospital

Scientists continue work to end chemotherapy pain

Scientists continue work to end chemotherapy pain

Researchers receive $6M grant to determine neuropathological condition of head injuries in non-athletes

Researchers receive $6M grant to determine neuropathological condition of head injuries in non-athletes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.